Skip to main content
Top
Published in: Clinical Rheumatology 9/2016

01-09-2016 | Brief Report

Psychological factors mediate key symptoms of fibromyalgia through their influence on stress

Authors: Katrina Malin, Geoffrey Owen Littlejohn

Published in: Clinical Rheumatology | Issue 9/2016

Login to get access

Abstract

The clinical features of fibromyalgia are associated with various psychological factors, including stress. We examined the hypothesis that the path that psychological factors follow in influencing fibromyalgia symptoms is through their direct effect on stress. Ninety-eight females with ACR 1990 classified fibromyalgia completed the following questionnaires: The Big 5 Personality Inventory, Fibromyalgia Impact Questionnaire, Perceived Stress Scale, Profile of Mood States, Mastery Scale, and Perceived Control of Internal States Scale. SPSS (PASW version 22) was used to perform basic t tests, means, and standard deviations to show difference between symptom characteristics. Pathway analysis using structural equation modelling (Laavan) examined the effect of stress on the relationships between psychological factors and the elements that define the fibromyalgia phenotype. The preferred model showed that the identified path clearly linked the psychological variables of anxiety, neuroticism and mastery, but not internal control, to the three key elements of fibromyalgia, namely pain, fatigue and sleep (p < 0.001), via the person’s perceived stress. Confusion, however, did not fit the preferred model. This study confirms that stress is a necessary link in the pathway between certain identified, established and significant psychological factors and key fibromyalgia symptoms. This has implications for the understanding of contributing mechanisms and the clinical care of patients with fibromyalgia.
Literature
1.
go back to reference Kivimaki M, Leino-Arjas P, Virtanen M, Elovainio M, Keltikangas-Jarvinen L, Puttonen S et al (2004) Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res 57(5):417–22PubMed Kivimaki M, Leino-Arjas P, Virtanen M, Elovainio M, Keltikangas-Jarvinen L, Puttonen S et al (2004) Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J Psychosom Res 57(5):417–22PubMed
2.
go back to reference Malin K, Littlejohn GO (2013) Stress modulates key psychological processes and characteristic symptoms in females with fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79):S64–71PubMed Malin K, Littlejohn GO (2013) Stress modulates key psychological processes and characteristic symptoms in females with fibromyalgia. Clin Exp Rheumatol 31(6 Suppl 79):S64–71PubMed
3.
go back to reference Hassett AL, Clauw DJ (2011) Does psychological stress cause chronic pain? Psychiatr Clin North Am 34(3):579–94CrossRefPubMed Hassett AL, Clauw DJ (2011) Does psychological stress cause chronic pain? Psychiatr Clin North Am 34(3):579–94CrossRefPubMed
4.
go back to reference Van Houdenhove B (2005) Premorbid “overactive” lifestyle and stress-related pain/fatigue syndromes. J Psychosom Res 58(4):389–90CrossRefPubMed Van Houdenhove B (2005) Premorbid “overactive” lifestyle and stress-related pain/fatigue syndromes. J Psychosom Res 58(4):389–90CrossRefPubMed
5.
go back to reference Low LA, Schweinhardt P (2012) Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012:1–15 Low LA, Schweinhardt P (2012) Early life adversity as a risk factor for fibromyalgia in later life. Pain Res Treat 2012:1–15
6.
go back to reference Gupta A, Silman AJ (2004) Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther 6(3):98–106CrossRefPubMedPubMedCentral Gupta A, Silman AJ (2004) Psychological stress and fibromyalgia: a review of the evidence suggesting a neuroendocrine link. Arthritis Res Ther 6(3):98–106CrossRefPubMedPubMedCentral
7.
go back to reference Thieme K, Turk DC (2012) Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia. Reumatismo 64(4):275–85CrossRefPubMed Thieme K, Turk DC (2012) Cognitive-behavioral and operant-behavioral therapy for people with fibromyalgia. Reumatismo 64(4):275–85CrossRefPubMed
8.
go back to reference Thieme K, Turk DC, Gracely R, Maxiner W, Flor H (2015) The relationship among psychological and psychophysiological characteristics of fibromyalgia patients. J Pain 16(2):186–96CrossRefPubMed Thieme K, Turk DC, Gracely R, Maxiner W, Flor H (2015) The relationship among psychological and psychophysiological characteristics of fibromyalgia patients. J Pain 16(2):186–96CrossRefPubMed
9.
go back to reference Malin K, Littlejohn G (2012) Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res 5:463–71PubMedPubMedCentral Malin K, Littlejohn G (2012) Psychological control is a key modulator of fibromyalgia symptoms and comorbidities. J Pain Res 5:463–71PubMedPubMedCentral
10.
go back to reference Malin K, Littlejohn G (2012) Neuroticism in young women with fibromyalgia links to key clinical features. Pain Res Treat 10:1–7 Malin K, Littlejohn G (2012) Neuroticism in young women with fibromyalgia links to key clinical features. Pain Res Treat 10:1–7
11.
go back to reference Malin K, Littlejohn G (2014) Psychological fibromyalgianess exists on a continuous spectrum. Austin J Orthop Rheumatol 1(1):1–7CrossRef Malin K, Littlejohn G (2014) Psychological fibromyalgianess exists on a continuous spectrum. Austin J Orthop Rheumatol 1(1):1–7CrossRef
12.
go back to reference Malin K, Littlejohn G (2015) Rumination modulates stress and other psychological processes in fibromyalgia. Eur J Rheumatol 4:143–8CrossRef Malin K, Littlejohn G (2015) Rumination modulates stress and other psychological processes in fibromyalgia. Eur J Rheumatol 4:143–8CrossRef
13.
go back to reference Wolfe F (1989) Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15(1):1–18PubMed Wolfe F (1989) Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am 15(1):1–18PubMed
14.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–72CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–72CrossRefPubMed
15.
go back to reference John OP, Robins RW, Pervin LA (1999) The big five personality inventory. In: Pervin LA, John O (eds) Handbook of Personality: Theory and Research. Guilford, New York, pp 103–138 John OP, Robins RW, Pervin LA (1999) The big five personality inventory. In: Pervin LA, John O (eds) Handbook of Personality: Theory and Research. Guilford, New York, pp 103–138
16.
go back to reference Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5):728–33PubMed Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18(5):728–33PubMed
17.
go back to reference Cohen S, Kamararck TRM (1983) A global measure of perceived stress. J Health Soc Behav 2:385–96CrossRef Cohen S, Kamararck TRM (1983) A global measure of perceived stress. J Health Soc Behav 2:385–96CrossRef
18.
go back to reference McNair D, Lorr M, Droppleman LF (1992) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, C.A McNair D, Lorr M, Droppleman LF (1992) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, C.A
19.
go back to reference Pallant J (2000) Development and validation of a scale to measure perceived control of internal states. J Pers Assess 2:308–37CrossRef Pallant J (2000) Development and validation of a scale to measure perceived control of internal states. J Pers Assess 2:308–37CrossRef
21.
go back to reference Rosseel Y (2012) Lavaan an R package for structural equation modeling. J Stat Softw 48(2):1–36CrossRef Rosseel Y (2012) Lavaan an R package for structural equation modeling. J Stat Softw 48(2):1–36CrossRef
22.
go back to reference Yanuar F, Ibrahim K, Jemain A (2010) On the application of structural equation modelling for the contrast of a health index. Environ Health Perv Med 15:285–91CrossRef Yanuar F, Ibrahim K, Jemain A (2010) On the application of structural equation modelling for the contrast of a health index. Environ Health Perv Med 15:285–91CrossRef
23.
go back to reference Boyer AL, Mira Pastor MA, Calatayud NP, Lopez-Roig S, Cantero Terol MC (2009) Comparing fibromyalgia patients from primary care and rheumatology settings: clinical and psychosocial features. Rheumatol Int 29(10):1151–60CrossRefPubMed Boyer AL, Mira Pastor MA, Calatayud NP, Lopez-Roig S, Cantero Terol MC (2009) Comparing fibromyalgia patients from primary care and rheumatology settings: clinical and psychosocial features. Rheumatol Int 29(10):1151–60CrossRefPubMed
24.
go back to reference Walen HR, Cronan PA, Bigatti SM (2001) Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 7:Spec No:SP39-47PubMed Walen HR, Cronan PA, Bigatti SM (2001) Factors associated with healthcare costs in women with fibromyalgia. Am J Manag Care 7:Spec No:SP39-47PubMed
Metadata
Title
Psychological factors mediate key symptoms of fibromyalgia through their influence on stress
Authors
Katrina Malin
Geoffrey Owen Littlejohn
Publication date
01-09-2016
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 9/2016
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-016-3315-9

Other articles of this Issue 9/2016

Clinical Rheumatology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine